END-OF-YEAR DRIVE: HOW YOU CAN HELP SUPPORT LOCAL NEWS

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Disc Medicine, Inc. - Common Stock (NQ:IRON)

78.29 -2.04 (-2.54%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 386,834
Open 80.79
Bid (Size) 78.16 (100)
Ask (Size) 78.29 (2,800)
Prev. Close 80.33
Today's Range 77.87 - 80.79
52wk Range 30.82 - 99.50
Shares Outstanding 22,877,552
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ ↗
Stat News on Friday raised concerns for Biopertin’s expedited approval under the FDA Commissioner's National Priority Voucher program. 
Via Stocktwits
News headline image
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire

Performance

YTD
+25.4%
+25.4%
1 Month
-14.6%
-14.6%
3 Month
+20.3%
+20.3%
6 Month
+47.8%
+47.8%
1 Year
+27.1%
+27.1%

More News

Read More
News headline image
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock ↗
Via The Motley Fool
News headline image
Disc Medicine Inc (NASDAQ:IRON) Reports Wider-Than-Expected Q3 2025 Loss Amid Pipeline Advancements ↗
Via Chartmill
News headline image
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Top stock movements in today's session. ↗
Via Chartmill
News headline image
Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings ↗
Via Benzinga
News headline image
Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
Which stocks are gapping on Friday? ↗
Via Chartmill
News headline image
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. ↗
Via Investor's Business Daily
News headline image
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times ↗
Via Benzinga
News headline image
Disc Medicine to Present Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2025 American Society of Nephrology (ASN) Kidney Week
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program ↗
Via Stocktwits
News headline image
Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides
Via MarketMinute
Topics Earnings Economy Intellectual Property
News headline image
Disc Medicine Announces Submission of New Drug Application (NDA) to US FDA for Accelerated Approval of Bitopertin for Patients with Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
From Disc Medicine Inc
Via GlobeNewswire

Frequently Asked Questions

Is Disc Medicine, Inc. - Common Stock publicly traded?
Yes, Disc Medicine, Inc. - Common Stock is publicly traded.
What exchange does Disc Medicine, Inc. - Common Stock trade on?
Disc Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Disc Medicine, Inc. - Common Stock?
The ticker symbol for Disc Medicine, Inc. - Common Stock is IRON on the Nasdaq Stock Market
What is the current price of Disc Medicine, Inc. - Common Stock?
The current price of Disc Medicine, Inc. - Common Stock is 78.29
When was Disc Medicine, Inc. - Common Stock last traded?
The last trade of Disc Medicine, Inc. - Common Stock was at 12/29/25 04:00 PM ET
What is the market capitalization of Disc Medicine, Inc. - Common Stock?
The market capitalization of Disc Medicine, Inc. - Common Stock is 1.79B
How many shares of Disc Medicine, Inc. - Common Stock are outstanding?
Disc Medicine, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article